I'm still trying to figure out why Eli Lily acquired point pharma. Their lead asset is equivocal for being BIC. Did they acquire then for their platform and/or manufacturing? @Davisite
On another note, if pluvicto ends up being equivocal in OS vs chemo and cu67 continues its current trajectory, it could mean cu67 may have a $5b TAM market to itself (after a H2H clinical trial vs chemo).
and then there is the nonPSMA PC asset, that covers ~20% of PC recurrence, currently without an approved radioligand therapy for it. Considering SABRE is probably going to be demonstrating uptake, the likelihood of success for therapy is higher.
it would seem like highway robbery if Alan isn't trying to court multiple pharmas.
- Forums
- ASX - By Stock
- CU6
- Research/Valuation
Research/Valuation, page-168
- There are more pages in this discussion • 239 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.09 |
Change
-0.210(4.88%) |
Mkt cap ! $1.272B |
Open | High | Low | Value | Volume |
$4.30 | $4.30 | $4.08 | $3.493M | 835.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 7459 | $4.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.12 | 9361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7459 | 4.090 |
1 | 2450 | 4.080 |
3 | 2089 | 4.070 |
1 | 10000 | 4.060 |
3 | 7617 | 4.050 |
Price($) | Vol. | No. |
---|---|---|
4.120 | 9361 | 1 |
4.160 | 10000 | 1 |
4.170 | 15000 | 1 |
4.190 | 600 | 1 |
4.240 | 1500 | 1 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
$4.10 |
  |
Change
-0.210 ( 4.15 %) |
|||
Open | High | Low | Volume | ||
$4.17 | $4.29 | $4.08 | 50363 | ||
Last updated 15.59pm 21/05/2024 ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
ATC
ALTECH BATTERIES LTD
Martin Stein, CFO
Martin Stein
CFO
Previous Video
Next Video
SPONSORED BY The Market Online